
    
      A Phase I, Open-Label, 3-way Crossover, Pharmacokinetic and Drug-Drug Interaction Study of
      ceftazidime avibactam (CAZ-AVI) and Metronidazole when Administered Alone and in Combination
      in Healthy Subjects
    
  